AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41

Authors: Klug, SJ Wilmotte, R Santos, C Almonte, M Herrero, R Guerrero, I Caceres, E Peixoto-Guimaraes, D Lenoir, G Hainaut, P Walboomers, JMM Munoz, N
Citation: Sj. Klug et al., TP53 polymorphism, HPV infection, and risk of cervical cancer, CANC EPID B, 10(9), 2001, pp. 1009-1012

Authors: Olivier, M Hainaut, P
Citation: M. Olivier et P. Hainaut, TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis, SEM CANC B, 11(5), 2001, pp. 353-360

Authors: Sepehr, A Taniere, P Martel-Planche, G Zia'ee, AA Rastgar-Jazii, F Yazdanbod, M Etemad-Moghadam, G Kamangar, F Saidi, F Hainaut, P
Citation: A. Sepehr et al., Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran, ONCOGENE, 20(50), 2001, pp. 7368-7374

Authors: Maurici, D Monti, P Campomenosi, P North, S Frebourg, T Fronza, G Hainaut, P
Citation: D. Maurici et al., Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay, ONCOGENE, 20(27), 2001, pp. 3533-3540

Authors: Vayssier-Taussat, M Camilli, T Aron, Y Meplan, C Hainaut, P Polla, BS Weksler, B
Citation: M. Vayssier-taussat et al., Effects of tobacco smoke and benzo[a] pyrene on human endothelial cell andmonocyte stress responses, AM J P-HEAR, 280(3), 2001, pp. H1293-H1300

Authors: Coche, EE Hamoir, XL Hammer, FD Hainaut, P Goffette, PP
Citation: Ee. Coche et al., Using dual-detector helical CT angiography to detect deep venous thrombosis in patients with suspicion of pulmonary embolism: Diagnostic value and additional findings, AM J ROENTG, 176(4), 2001, pp. 1035-1039

Authors: Pluquet, O Hainaut, P
Citation: O. Pluquet et P. Hainaut, Genotoxic and non-genotoxic pathways of p53 induction, CANCER LETT, 174(1), 2001, pp. 1-15

Authors: Guimaraes, DP Lu, SH Snijders, P Wilmotte, R Herrero, R Lenoir, G Montesano, R Meijer, CJLM Walboomers, J Hainaut, P
Citation: Dp. Guimaraes et al., Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China, CANCER LETT, 162(2), 2001, pp. 231-235

Authors: Hainaut, P Olivier, M Pfeifer, GP
Citation: P. Hainaut et al., TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database, MUTAGENESIS, 16(6), 2001, pp. 551-553

Authors: Hainaut, P Pfeifer, GP
Citation: P. Hainaut et Gp. Pfeifer, Patterns of p53 G -> T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke, CARCINOGENE, 22(3), 2001, pp. 367-374

Authors: DeMarini, DM Landi, S Tian, DF Hanley, NM Li, XM Hu, FD Roop, BC Mass, MJ Keohavong, P Gao, WM Olivier, M Hainaut, P Mumford, JL
Citation: Dm. Demarini et al., Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions, CANCER RES, 61(18), 2001, pp. 6679-6681

Authors: Taniere, P Martel-Planche, G Saurin, JC Lombard-Bohas, C Berger, F Scoazec, JY Hainaut, P
Citation: P. Taniere et al., TP53 mutations, amplification of P63 and expression of cell cycle proteinsin squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe, BR J CANC, 85(5), 2001, pp. 721-726

Authors: Chazotte-Aubert, L Pluquet, O Hainaut, P Ohshima, H
Citation: L. Chazotte-aubert et al., Nitric oxide prevents gamma-radiation-induced cell cycle arrest by impairing p53 function in MCF-7 cells, BIOC BIOP R, 281(3), 2001, pp. 766-771

Authors: Taniere, P Martel-Planche, G Maurici, D Lombard-Bohas, C Scoazec, JY Montesano, R Berger, F Hainaut, P
Citation: P. Taniere et al., Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia, AM J PATH, 158(1), 2001, pp. 33-40

Authors: Kirk, GD Camus-Randon, AM Mendy, M Goedert, JJ Merle, P Trepo, C Brechot, C Hainaut, P Montesano, R
Citation: Gd. Kirk et al., Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia, J NAT CANC, 92(2), 2000, pp. 148-153

Authors: Hall, J Hainaut, P
Citation: J. Hall et P. Hainaut, Special issue in honor of Ruggiero Montesano - Preface, MUT RES-R M, 462(2-3), 2000, pp. 51-51

Authors: Mandard, AM Hainaut, P Hollstein, M
Citation: Am. Mandard et al., Genetic steps in the development of squamous cell carcinoma of the esophagus, MUT RES-R M, 462(2-3), 2000, pp. 335-342

Authors: North, S El-Ghissassi, F Pluquet, O Verhaegh, G Hainaut, P
Citation: S. North et al., The cytoprotective aminothiol WR1065 activates p21(waf-1) and down regulates cell cycle progression through a p53-dependent pathway, ONCOGENE, 19(9), 2000, pp. 1206-1214

Authors: Meplan, C Richard, MJ Hainaut, P
Citation: C. Meplan et al., Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intactcells, ONCOGENE, 19(46), 2000, pp. 5227-5236

Authors: Cortes, U Moyret-Lalle, C Falette, N Duriez, C El Ghissassi, F Barnas, C Morel, AP Hainaut, P Magaud, JP Puisieux, A
Citation: U. Cortes et al., BTG gene expression in the p53-dependent and -independent cellular response to DNA damage, MOL CARCINO, 27(2), 2000, pp. 57-64

Authors: Hainaut, P
Citation: P. Hainaut, Detection of circulating tumour DNA in the blood of cancer patients, M S-MED SCI, 16(3), 2000, pp. 446-446

Authors: North, S Hainaut, P
Citation: S. North et P. Hainaut, p53 and cell-cycle control: a finger in every pie, PATH BIOL, 48(3), 2000, pp. 255-270

Authors: Hainaut, P Hollstein, M
Citation: P. Hainaut et M. Hollstein, p53 and human cancer: The first ten thousand mutations, ADV CANC R, 77, 2000, pp. 81-137

Authors: Taniere, P Martel-Planche, G Puttawibul, P Casson, A Montesano, R Chanvitan, A Hainaut, P
Citation: P. Taniere et al., TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in South Thailand, INT J CANC, 88(2), 2000, pp. 223-227

Authors: Buller, HR Cariou, R Gallus, A Gent, M Ginsberg, J Prins, MH Lensing, A Levi, M Nurmohammed, N Hirsh, J Roberts, R ten Cate, JW Decousus, H Mismetti, P Buchmuller, A Charlet, V Viallon, A van der Meer, J Meinardi, JR Meijer, K Piovella, F Barone, M Beltrametti, C Serafini, S Kraaijenhagen, RA Koopman, MMW Jagt, HHT Muller, MBR Kooy, MV Nauta, S Gallus, AS Coghlan, D Rich, C Prandoni, P Scudeller, A Scarano, L Girolami, A Baker, R Tan, E Cooney, J Eikelboom, J Ninet, J Dolmazon, C Madoux, MHG Coppere, B Nenci, GG Agnelli, G Falcinelli, F Morini, M d'Angelo, A Crippa, L d'Angelo, SV Chong, B Chestreman, C Malvin, J Eisbacher, M MacGillavry, MR Brandjes, DPM Beaumont, JFM Olmos, RAV Turpie, AGG Johnson, J Nowacki, B Anderson, D Pleasance, S Mitchell, M Ockelford, P Bennett, A Jones, R Porteous, F Weitz, J Kearon, C Simonneau, G Parent, F Douketis, J Schnurr, T Hainaut, P Petit, B Jaumotte, C Huisman, MV van Poelgeest, MIE Meinders, AE van Oostayen, JA Beer, J Lugli, A Pederiva, S Ginsberg, J Brill-Edwards, P Stevens, P Bassand, JP Seronde, MF Kassis, J Fortin, M Faivre, R Petiteau, PY Verhaeghe, R Wells, P Lewandowski, B Touchie, D Banga, JD Hartmann, IJC Zeguers, VJM Desjardins, L Villeneuve, J Cote, J Bounameaux, H Cirafici, P Demers, C van der Heul, C Kruip, M
Citation: Hr. Buller et al., Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation, CIRCULATION, 102(22), 2000, pp. 2726-2731
Risultati: 1-25 | 26-41